novo nordisk glp 1 drug Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Novo Nordisk cuts GLP-1 prices
Description
A large retrospective study found that patients who used phentermine continuously for more than 12 months maintained greater weight loss at 24 months (7.4% more than the referent group) without increased cardiovascular risk
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro
[DOI] [PubMed] [Google Scholar] Kreymann B
doi:10.3109/00365521.2013.832366 85
